Relaxin-3 mRNA levels in nucleus incertus correlate with alcohol and sucrose intake in rats

Drug and Alcohol Dependence

Volumn 140, Issue , 2014, Pages 8-16

  Ryan, P J ^a,b,e   Krstew, E V ^a   Sarwar, M ^d   Gundlach, A L ^a,b,c   Lawrence, A J ^a,b  

^a FLOREY INSTITUTE OF NEUROSCIENCE AND MENTAL HEALTH   (Australia)

^b UNIVERSITY OF MELBOURNE   (Australia)

^c UNIVERSITY OF MELBOURNE   (Australia)

^d MONASH UNIVERSITY   (Australia)

^e UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

Author keywords

Alcohol; MRNA; Neuropeptides; Nucleus incertus; Relaxin 3; RXFP3

Indexed keywords

ALCOHOL; MESSENGER RNA; RELAXIN 3; SUCROSE; G PROTEIN COUPLED RECEPTOR; RECEPTOR; RXFP3 PROTEIN, RAT;

ALCOHOL CONSUMPTION; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; AUTORADIOGRAPHY; CONTROLLED STUDY; CORRELATIONAL STUDY; GENE EXPRESSION; GENE FUNCTION; HISTOCHEMISTRY; IN SITU HYBRIDIZATION; IN VITRO STUDY; LIGAND BINDING; MALE; NEUROMODULATION; NONHUMAN; NUCLEUS INCERTUS; PRIORITY JOURNAL; PROTEIN EXPRESSION; QUANTITATIVE ANALYSIS; RAT; REWARD; RHOMBENCEPHALON; RXFP3 GENE; SUGAR INTAKE; ANIMAL; BIOSYNTHESIS; DRINKING; DRINKING BEHAVIOR; DRUG EFFECTS; EATING; GENETICS; METABOLISM; PHYSIOLOGY; PSYCHOLOGY; RAPHE NUCLEUS;

RATTUS;

ALCOHOL DRINKING; ANIMALS; DRINKING; EATING; MALE; RAPHE NUCLEI; RATS; RECEPTORS, G-PROTEIN-COUPLED; RECEPTORS, PEPTIDE; RHOMBENCEPHALON; RNA, MESSENGER; SUCROSE;

EID: 84924848867     PISSN: 03768716     EISSN: 18790046     Source Type: Journal    
DOI: 10.1016/j.drugalcdep.2014.04.017     Document Type: Article

References (45)

1. Bachtell R.K., Weitemier A.Z., Galvan-Rosas A., Tsivkovskaia N.O., Risinger F.O., Phillips T.J., Grahame N.J., Ryabinin A.E. The Edinger-Westphal-lateral septum urocortin pathway and its relationship to alcohol consumption. J. Neurosci. 2003, 23:2477-2487.
2. Banerjee A., Shen P.J., Ma S., Bathgate R.A.D., Gundlach A.L. Swim stress excitation of nucleus incertus and rapid induction of relaxin-3 expression via CRF1 activation. Neuropharmacology 2010, 58:145-155.
3. Bathgate R.A.D., Lin F., Hanson N.F., Otvos L., Guidolin A., Giannakis C., Bastiras S., Layfield S.L., Ferraro T., Ma S., Zhao C., Gundlach A.L., Samuel C.S., Tregear G.W., Wade J.D. Relaxin-3: improved synthesis strategy and demonstration of its high-affinity interaction with the relaxin receptor LGR7 both in vitro and in vivo. Biochemistry 2006, 45:1043-1053.
4. Blasiak A., Blasiak T., Lewandowski M.H., Hossain M.A., Wade J.D., Gundlach A.L. Relaxin-3 innervation of the intergeniculate leaflet of the rat thalamus - neuronal tract-tracing and in vitro electrophysiological studies. Eur. J. Neurosci. 2013, 37:1284-1294.
5. Blasiak A., Gundlach A.L., Lewandowski M.H. Orexins increase nucleus incertus neuronal activity: implications for a possibly reinforcing a arousal drive. FENS Abstracts 2010, 5:104. 102.
6. Burazin T.C.D., Bathgate R.A.D., Macris M., Layfield S., Gundlach A.L., Tregear G.W. Restricted, but abundant, expression of the novel rat gene-3 (R3) relaxin in the dorsal tegmental region of brain. J. Neurochem. 2002, 82:1553-1557.
7. Chen F., Rezvani A., Jarrott B., Lawrence A.J. Distribution of GABAA receptors in the limbic system of alcohol-preferring and non-preferring rats: in situ hybridisation histochemistry and receptor autoradiography. Neurochem. Int. 1998, 32:143-151.
8. Gundlach A.L., O'Shea R.D. Quantitative analysis of in situ hybridization histochemistry. Int. Rev. Neurobiol. 2002, 47:135-170.
9. Heilig M., Koob G.F. A key role for corticotropin-releasing factor in alcohol dependence. Trends Neurosci. 2007, 30:399-406.
10. Kampov-Polevoy A.B., Garbutt J.C., Janowsky D.S. Association between preference for sweets and excessive alcohol intake: a review of animal and human studies. Alcohol Alcoholism 1999, 34:386-395.
11. Koob G.F. A role for brain stress systems in addiction. Neuron 2008, 59:11-34.
12. Lawrence A.J. Regulation of alcohol-seeking by orexin (hypocretin) neurons. Brain Res. 2010, 1314:124-129.
13. Lawrence A.J., Cowen M.S., Yang H.J., Chen F., Oldfield B. The orexin system regulates alcohol-seeking in rats. Brit. J. Pharmacol. 2006, 148:752-759.
14. Lawrence A.J., Krstew E., Jarrott B. Actions of nitric oxide and expression of the mRNA encoding nitric oxide synthase in rat vagal afferent neurons. Eur. J. Pharmacol. 1996, 315:127-133.
15. Lenglos C., Mitra A., Guevremont G., Timofeeva E. Sex differences in the effects of chronic stress and food restriction on body weight gain and brain expression of CRF and relaxin-3 in rats. Genes Brain Behav. 2013, 12:370-387.
16. Liu C., Chen J., Kuei C., Sutton S., Nepomuceno D., Bonaventure P., Lovenberg T.W. Relaxin-3/insulin-like peptide 5 chimeric peptide, a selective ligand for G protein-coupled receptor (GPCR)135 and GPCR142 over leucine-rich repeat-containing G protein-coupled receptor 7. Mol. Pharmacol. 2005, 67:231-240.
17. Lodge D.J., Lawrence A.J. Comparative analysis of the central CCK system in Fawn Hooded and Wistar Kyoto rats: extended localisation of CCK-A receptors throughout the rat brain using a novel radioligand. Regul. Pept. 2001, 99:191-201.
18. Ma S., Blasiak A., Olucha-Bordonau F.E., Verberne A.J., Gundlach A.L. Heterogeneous responses of nucleus incertus neurons to corticotrophin-releasing factor and coherent activity with hippocampal theta rhythm in the rat. J. Physiol. 2013, 591:3981-4001.
19. Ma S., Bonaventure P., Ferraro T., Shen P.J., Burazin T.C., Bathgate R.A.D., Liu C., Tregear G.W., Sutton S.W., Gundlach A.L. Relaxin-3 in GABA projection neurons of nucleus incertus suggests widespread influence on forebrain circuits via G-protein-coupled receptor-135 in the rat. Neuroscience 2007, 144:165-190.
20. Ma S., Sang Q., Lanciego J.L., Gundlach A.L. Localization of relaxin-3 in brain of Macaca fascicularis: identification of a nucleus incertus in primate. J. Comp. Neurol. 2009, 517:856-872.
21. Madeira M.D., Sousa N., Lieberman A.R., Paula-Barbosa M.M. Effects of chronic alcohol consumption and of dehydration on the supraoptic nucleus of adult male and female rats. Neuroscience 1993, 56:657-672.
22. Martin-Fardon R., Boutrel B. Orexin/hypocretin (Orx/Hcrt) transmission and drug-seeking behavior: is the paraventricular nucleus of the thalamus (PVT) part of the drug seeking circuitry?. Front. Behav. Neurosci. 2012, 6:75.
23. Munro J., Skrobot O., Sanyoura M., Kay V., Susce M.T., Glaser P.E., de Leon J., Blakemore A.I., Arranz M.J. Relaxin polymorphisms associated with metabolic disturbance in patients treated with antipsychotics. J. Psychopharmacol. 2012, 26:374-379.
24. Nestler E.J. Is there a common molecular pathway for addiction?. Nat. Neurosci. 2005, 8:1445-1449.
25. Paxinos G., Watson C. The Rat Brain in Stereotaxic Coordinates: Compact Third Edition 1997, Academic Press, London.
26. Paxinos G., Watson C. The Rat Brain in Stereotaxic Coordinates 2007, Academic Press, London.
27. Pickering C., Avesson L., Liljequist S., Lindblom J., Schioth H.B. The role of hypothalamic peptide gene expression in alcohol self-administration behavior. Peptides 2007, 28:2361-2371.
28. Rajkumar R., See L.K., Dawe G.S. Acute antipsychotic treatments induce distinct c-Fos expression patterns in appetite-related neuronal structures of the rat brain. Brain Res. 2013, 1508:34-43.
29. Rivier C., Imaki T., Vale W. Prolonged exposure to alcohol: effect on CRF mRNA levels, and CRF- and stress-induced ACTH secretion in the rat. Brain Res. 1990, 520:1-5.
30. Ryabinin A.E., Weitemier A.Z. The urocortin 1 neurocircuit: ethanol-sensitivity and potential involvement in alcohol consumption. Brain Res. Rev. 2006, 52:368-380.
31. Ryan P.J., Kastman H.E., Krstew E.V., Rosengren K.J., Hossain M.A., Churilov L., Wade J.D., Gundlach A.L., Lawrence A.J. Relaxin-3/RXFP3 system regulates alcohol-seeking. Proc. Natl. Acad. Sci. USA 2013, 110:20789-20794.
32. Ryan P.J., Ma S., Olucha-Bordonau F.E., Gundlach A.L. Nucleus incertus - an emerging modulatory role in arousal, stress and memory. Neurosci. Biobehav. Rev. 2011, 35:1326-1341.
33. Sanchis-Segura C., Spanagel R. Behavioural assessment of drug reinforcement and addictive features in rodents: an overview. Addict. Biol. 2006, 11:2-38.
34. Silva S.M., Madeira M.D., Ruela C., Paula-Barbosa M.M. Prolonged alcohol intake leads to irreversible loss of vasopressin and oxytocin neurons in the paraventricular nucleus of the hypothalamus. Brain Res. 2002, 925:76-88.
35. Smith C.M., Hosken I.T., Sutton S.W., Lawrence A.J., Gundlach A.L. Relaxin-3 null mutation mice display a circadian hypoactivity phenotype. Genes Brain Behav. 2012, 11:94-104.
36. Smith C.M., Ryan P.J., Hosken I.T., Ma S., Gundlach A.L. Relaxin-3 systems in the brain - the first 10 years. J. Chem. Neuroanat. 2011, 42:262-275.
37. Smith C.M., Shen P.J., Banerjee A., Bonaventure P., Ma S., Bathgate R.A.D., Sutton S.W., Gundlach A.L. Distribution of relaxin-3 and RXFP3 within arousal, stress, affective, and cognitive circuits of mouse brain. J. Comp. Neurol. 2010, 518:4016-4045.
38. Sommer W.H., Rimondini R., Hansson A.C., Hipskind P.A., Gehlert D.R., Barr C.S., Heilig M.A. Upregulation of voluntary alcohol intake, behavioral sensitivity to stress, and amygdala crhr1 expression following a history of dependence. Biol. Psychiat. 2008, 63:139-145.
39. Sutton S.W., Bonaventure P., Kuei C., Roland B., Chen J., Nepomuceno D., Lovenberg T.W., Liu C. Distribution of G-protein-coupled receptor (GPCR)135 binding sites and receptor mRNA in the rat brain suggests a role for relaxin-3 in neuroendocrine and sensory processing. Neuroendocrinology 2004, 80:298-307.
40. Tanaka M., Iijima N., Miyamoto Y., Fukusumi S., Itoh Y., Ozawa H., Ibata Y. Neurons expressing relaxin 3/INSL 7 in the nucleus incertus respond to stress. Eur. J. Neurosci. 2005, 21:1659-1670.
41. Ubaldi M., Bifone A., Ciccocioppo R. Translational approach to develop novel medications on alcohol addiction: focus on neuropeptides. Curr. Opin. Neurobiol. 2013, 23:684-691.
42. Volkow N.D., Wang G.J., Tomasi D., Baler R.D. The addictive dimensionality of obesity. Biol. Psychiat. 2013, 73:811-818.
43. Volkow N.D., Wang G.J., Tomasi D., Baler R.D. Obesity and addiction: neurobiological overlaps. Obes. Rev. 2013, 14:2-18.
44. Weitemier A.Z., Ryabinin A.E. Brain region-specific regulation of urocortin 1 innervation and corticotropin-releasing factor receptor type 2 binding by ethanol exposure. Alcohol.Clin. Exp. Res. 2005, 29:1610-1620.
45. Zorrilla E.P., Heilig M., de Wit H., Shaham Y. Behavioral, biological, and chemical perspectives on targeting CRF(1) receptor antagonists to treat alcoholism. Drug Alcohol Depend. 2013, 128:175-186.